Our news archive includes ground-breaking news and research from the past 12 months. To make your search easier try to pick a key word or phrase. People often search for ‘MS drugs’ or ‘treatment trials’.
The news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.
Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.
Study finds lipid antibodies reflect changes in brain volume and lesions (10/02/16) Brigham and Women’s Hospital researchers are claiming that antibodies directed at lipids are associated with magnetic resonance imaging (MRI) measures of brain degeneration in patients with multiple sclerosis (MS), and may potentially serve as biomarkers for monitoring disease status...Read more
New recommendations on MRI diagnosis of multiple sclerosis (10/02/16) New revisions to the MRI criteria for the diagnosis of multiple sclerosis have been proposed...Read more
Microsoft and Novartis team up to tackle multiple sclerosis (10/02/16) Microsoft and Novartis are joining forces to help people living with multiple sclerosis. Using Microsoft’s Kinect, they have developed a tool called Assess MS which can monitor and evaluate a patient’s movements to determine if the disease is progressing or not...Read more
Treatment improves brain inflammation in multiple sclerosis (09/02/16) A novel therapeutic approach to multiple sclerosis (MS) patients may be effective in reducing brain inflammation, according to findings published in the Journal of Neuroinflammation...Read more
Brain scars reveal possible cause of taste problems (09/02/16) Taste deficits appear to be more prevalent among multiple sclerosis (MS) patients than previously reported and correlate with brain lesions, a new study from the University of Pennsylvania's Smell and Taste Centre and the department of Radiology has found...Read more
Study suggests remarkable approach to MS treatment (08/02/16) A group of researchers at the Stanford Department of Neurology and Neurological Sciences exploring the use of a synthetic bile acid agonist in a mouse model of multiple sclerosis say they have seen some remarkable results...Read more
Experimental therapy Trimesta fails to demonstrate efficacy (08/02/16) Synthetic Biologics has revealed disappointing results from an independent third-party analysis of a Phase II clinical trial evaluating Trimesta as a treatment for relapsing-remitting multiple sclerosis (RRMS) in women...Read more
Tysabri ‘more effective’ than Gilenya, study claims (08/02/16) A retrospective analysis has found Tysabri is more effective than Gilenya in preventing relapses in patients with relapsing-remitting multiple sclerosis (RRMS)...Read more
Multiple sclerosis patients who undergo infertility treatments have higher relapse rates (05/02/16) New research published in Annals of Neurology has found multiple sclerosis patients who undergo assisted reproduction technology (ART) face a higher risk of disease activity and multiple sclerosis relapse...Read more
Natural protein points to new treatment (05/02/16) Increasing the level of a naturally-produced protein, called tristetraprolin (TTP), significantly reduced or protected mice from inflammation, according to researchers at the National Institutes of Health...Read more
Nearly 14,000 have mobility cars taken away (05/02/16) Nearly 14,000 disabled people who rely on a specialist motoring allowance have had their cars taken away from them following government welfare changes...Read more
Biogen report drop in profits (04/02/16) Pharmaceutical giant Biogen has reported declining fourth-quarter profits but still topped most expectations as sales of its treatment for multiple sclerosis took off...Read more
New MRI technique offers faster multiple sclerosis diagnosis (02/02/16) A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers at The University of Nottingham and Nottingham University Hospitals NHS Trust...Read more
Government told to restrict Gabapentin and Pregabalin availability (28/01/16) The prescription drugs gabapentin and pregabalin could soon be more tightly regulated in the UK, after Government advisors called for them to be classed as controlled drugs...Read more